re: reasons sirtex is best value in biotech phee, not sure what you mean by that...
the 2005 report looks good. Couple of hiccups, but seems sorted now. The 40% increase 2nd half sales revenue great, and patents ok, except US, but they believe it shouldn't effect sales. Marketing strategy evolving. All in all, with my very little knowledge so far, seems like the time to is nigh to get in early; right price.
civil action, page-36
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.24M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $109.3K | 836.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 365703 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 812922 | 5 |
View Market Depth
| Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |